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ABSTRACT 
Effects of barbiturates on 
A 1adenosine receptors of rat 
brain 
Pharmakologisches Institut, Im Neuenheimer Feld 366, 
D-6900 Heidelberg, FAG 
Barbiturates inhibit binding of radioligands to A
1 
(Ri) 
adenosine receptors of rat brain membranes. This inhibition is 
dose-dependent and stereospecific and occurs in the range of 
pharmacologically active concentrations. The displacement of 
radiolabelled A1antagonists by barbiturates is not modified by 
GTP, indicating that barbiturates might act as antagonists at 
this receptor. This action of barbiturates does not seem to be 
related to the binding of barbiturates to plasma membranes, as 
the latter process has different characteristics. Barbiturates 
also inhibit the binding of radioligands to solubilized A1re-
ceptors, and saturation and kinetic experiments suggest that 
this is due to a competitive antagonism. These results indicate 
that barbiturates interact with the recognition site of the 
A1adenosine receptor. 
INTRODUCTION 
Adenosine appears to play an important neuromodulatory role 
in the central nervous system (1). Amongst its mostprominent 
properties is the profound sedation which can be induced by 
adenosine and its analogues; this effect appears to be mediated 
by the A1 receptor subtype and conversely A1receptor 
antagonists such as the methylxanthines are CNS-stimulants {2). 
Therefore it seems plausible that also drugs which depress the 
central nervaus system might act via A1 receptors. This hypo-
thesis led us to investigate the effects of barbiturates, one of 
the major groups of CNS-depressants, on radioligand binding to 
A1 adenosine receptors of brain membranes. 
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METHODS 
~ P2-membrane fraction from rat brain was prepared accord-
ing to Whittaker (3). Binding of [ 3 H] (-)N 6-phenylisopropyl-
adenosine ( [ 3H] PIA, 1 nM) and of ( 3H]diethylphenylxanthine 
( [ 3H ) DPX, 10 nM) to A1 adenosine re·ceptors was done at 3 7°C 
for membranes and at 25°C for solubilized receptors essential-
ly as described (4,5). Bound and free radioligand were separated 
by rapid filtration. The data were analysed by non-linear curve-
fitting as described (6). 
RESULTS 
Effects of barbiturates on A1receptor radioligand binding to 
brain membranes. 
Initially the binding of [ 3H]PIA to a P
2
-membrane prep-
aration from rat brain was studied. Barbiturates inhibit the 
specific binding of [ 3H]PIA in a dose-dependent manner. Figure 
1 shows the inhibition by pentobarbital and phenobarbital. Both 
curves appear to be monophasic with linear Hill plots and slope 
factors of 0.90 (pentobarbital) and 0.98 (phenobarbital). Non-
linear curve-fitting confirms the homogeneity of the sites. 
The Ki-values of other barbiturates tagether with some CNS-
depressants are given in Table 1. DMBB (5-(1,3-dimethylbutyl)-5-
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Figure 1 Inhibition of [ 3H]PIA binding to rat brain membranes by 
pentobarbital (circles) and phenobarbital (triangles). Theinset 
shows the Hill plot. Data from ref. 5. 
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ethyl-barbituric acid) is the most potent compound, and the 
(-)stereoisomer has a K.-value about 4 times lower than the 
J.. 
(+)stereoisomer. Stereospecificity, although to a smaller ex-
tent, is also observed for mephobarbital and hexobarbital. In 
each case the more sedative compound is the more potent in dis-
placing [ 3H]PIA. Thiopental and methohexital~ which are very 
lipid-soluble, are less potent than pentobarbital; thus, there 
is no correlation between lipid-solubility and potency in 
inhibiting binding of ( 3H]PIA. Barbituric acid which lacks 
CNS-depr-essant activity does not inhibit binding of [ 3H] PIA in 
concentrations up to 1 mM. Other sedative-hypnotic drugs such as 
the benzodiazepines triazolam and oxazepam and the antihistamine 
diphenhydramine are inactive in concentrations up to 1 mM or 
those maximally obtainable in aqueous solutions. 
The affinity of agonists to A1 receptors is markedly reduced 
in the presence of GTP, whereas the affinity of antagonists is 
not altered (7). It is thought that GTP induces the state of low 
affinity for agonists by uncoupling the receptor and the GTP-
regulatory protein N. (6). This effect is demonstrated in 
1 
Table 1 Inhibition of [ 3H]PIA binding to rat brain membranes. 
Compounds Ki confidence 
(~l/lJ 1 fm1ts (IJifiOlll) 
(- )DMBB 24 17 - 33 
(+)OMBB 82 71 - 95 
( + )Mephobarbi tal 352 277 - 449 
{-)Mephobarbital 578 467 - 687 
(+)Hexobarbita1 425 378 - 478 
(- )Hexoba rbi ta 1 622 564 - 686 
( :t) Pentoba rbi ta 1 92 59 - 146 
Amobarbi ta 1 133 102 - 174 
Thiopenta J 134 92 - 196 
Methohexital 344 339 - 350 
Phenoba rb i ta l 356 275 - 463 
Barbituric ac id >1,000 
Diphenhydramin >1,000 
Triazotam > 300 
Oxazepam > 300 
Ki-values are given as means and 95% confidence limits. Data 
from ref. 5 and unpublished. 
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3H] DPX' used, GTP Figure 2. When the antagonist radioligand [ ~s 
shifts the inhibition curve of the agonist to higher concentrat-
ions while not affecting the curve of the agonist. In addition 
GTP does not alter the inhibition curve of pentobarbital. This 
indicates that barbiturates are not agonists at the Alre-
ceptor. 
Binding of barbiturates to brain membranes 
The interaction of barbiturates with radioligand binding to 
~ 1 receptors may basically occur at three different sites: 
1) at the GTP-regulatory protein N. which is known to modify 
1 
the receptor, 2) at the plasma membrane which in turn has influ-
ences on the receptor, and 3) at the receptor itself. The first 
possibility is unlikely because of two findings: firstly barbit-
urates inhibit [ 3H]DPX binding which is not subject to influ-
ences by Ni, and secondly the effects of barbiturates are the 
same when GTP is present which uncouples the receptor and Ni. 
Effects of barbiturates an plasma membranes have been claimed 
tobe responsible for their pharmacological activity (8). There-
fore we have investigated the binding of radiolabelled barbit-
urates to plasma membranes. [ 3H] Phenobarbital binds in a 
saturable manner to a P 2-fraction from rat brain (Figure 3) • 
However, the very high Brnax-value of 2.7 nmol/mg protein 
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Figure 3 Saturation isotherm of ( 3H]phenobarbital binding to 
rat brain membranes. The inset shows the Scatchard plot. Data 
from ref. 9. 
indicates, that ~he binding site is not a receptor protein. This 
is confirmed by the fact that the binding is not influenced by 
temperatures up to 95°C for 20 min. It seems more likely that 
the binding occurs to membrane lipids. In this case it should be 
relatively sensitive to detergents. Figure 4 shows that this is 
indeed true. Various detergents in concentrations as low as 0.1% 
to 0.2% drastically reduce the binding of [ 3H)phenobarbital. 
On the other hand, the binding of [ 3H]PIA to the same mem-
branes at these detergent concentrations is rather increased, 
and the effects of barbiturates are the same as in the absence 
of detergents (data not shown). Thus, effects of barbiturates on 
~lreceptors can be observed under conditions where the binding 
of barbiturates to the plasma membrane is abolished. 
Therefore the effects of barbiturates on A1receptors do not 
appear to be related to the binding of barbiturates to plasma 
membranes. 
Effects of barbiturates on radioligand binding to solubilized 
~ 1 receptors 
Given the observations that barbiturates appear to inhibit 
radioligand binding 
the plasma membrane, 
to 
we 
A1receptors 
considered 
neither via 
the possibility 
N. nor via 
~ 
that they 
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Figure 4 Effects of detergents on [ 3H]phenobarbital binding to 
rat brain membranes. Data from ref. 9. 
might interact with the receptor itself. Receptors from rat 
brain P2-membranes were solubilized with 1% CHAPS (3-((3-chol-
amidopropyl)-dimethylammonio)-propanesulfonate) and separated 
from plasma membranes by high speed centrifugation. Binding of 
... io .. io-~ 
Conc~ntration of borbi tura t~ ( M) 
et-)0M88 
o (•tDMBB 
• (-)P't'BB 
o I+)MPBB 
F~gure 5 lnh~b~t~on of [ 3H]PIA b~nding to solubil~zed A
1
receptors 
from rat bra~n by the stereo~somers of DMBB and MPPB. Unpublished 
data. 
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[3 H]PIA to the solubilized receptor is inhibited by barbiturat-
es in the same concentrations as in plasma membranes (Figure 5). 
~gain the (-)stereoisomer of DMBB is about 4 times more potent 
than the (+)stereoisomer (K. 21 J,t.M vs 80 JJ.M), and a slightly 
1 
lesser degree of stereospecificity is observed for MPPB (N-
methyl-5-phenyl-5-propylbarbituric acid; K. 210 ~M vs 320 ~M). 
1 
The saturation isotherm for [ 3 H]PIA binding to the solubil-
ized receptor is markedly shifted to higher concentrations in 
the presence of 100 ~M (±)DMBB, but the same amount of 
maximal binding is eventually obtained. Analysis by non-linear 
curve-fitting shows a marked decrease of the apparent K0 -value 
from 0.72 nM to 3.7 nM, but no change of the B -value (721 
max 
vs 743 fmol/mg protein). This indicates competitive antagonism. 
The Schild equation gives a pA 2-value for (!)DMBB of 4.6 
corresponding to a K. of 25 J.LM, which agrees well with the 
1 
values obtained from the inhibition curves. 
The competitive antagonism suggests an interaction of barbit-
urates with the recognition site of the A1receptor. If this is 
the mechanism, then the dissociation of [ 3H1 PIA from the re-
cognition site should be the same after addition of a high ex-
cess of either an unlabelled A1 receptor ligand or barbiturate. 
Figure 7 demonstrates this for theophylline and pentobarbital. 
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Figure 6 Effect of 100 ~M (!)DMBB on the saturation isotherm of 
3 [ H]PIA binding to solubilized A 1 re~eptors from rat brain. The 
inset shows the scatchard plot. unpublished data. 
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Figure 7 Dissociation of [ 3H]PIA binding to solubilized A1re-
ceptors from rat brain. After attainment of equilibrium the 
dissociation was initiated by addition of 1 mM theophylline or 
10 mM pentobarbital. The inset shows the first order plot. 
Unpublished data. 
The dissociation curves are identical for the two compounds. It 
appears, therefore, that barbiturates interact with the 
recognition site of the ~ 1 receptor. 
DISCUSSION 
Our results indicate that barbiturates interact with ~ 1 aden­
osine receptors in the central nervous system. The competitive 
nature of this interaction and the identity of the dissociation 
curve after addition of an excess of ~ 1 receptor ligands and 
barbiturates suggest that barbiturates act at the recognition 
site itself. This effect of barbiturates is not modulated by GTP 
and therefore it appears that barbiturates are antagonists at the 
~ 1 adenosine receptor. 
The role of membrane proteins in the 
barbiturates and other anaesthetics is 
mechanism of action of 
still under debate (10). 
~n inhibition of pure luciferase by a variety of anaesthetics 
underlines the possibility that proteins may be modulated 
directly and not via alterations of plasma membrane properties 
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(11). Our study raises the possibility lhat such an inter~ction 
with ~~ receptors may indeed occur in the central nervaus 
system at hypnotic/anaesthetic concentrations. Thus, brain levels 
of pentobarbital during anaesthesia in the rat have been repor.le~ 
tobe 200-300 j.J.mol/kg (12); the K.-value in inhibiting binding 
of [ 3H]PIA is about 100 IJ.M. 
1 
Recently two groups reported inhibition of radioligand binding 
to A1adenosine receptors by the anticonvulsant carbamazepine 
(13,14). Although the exact nature of this effect remains tobe 
elucidated it supports the idea that CNS-depressant drugs may 
exert their effects via A1 adenosine receptors. 
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DISCUSSION 
Fredholm: 
Isn't it possible that you could have some kind of an agonist 
s ta te wh ich is not necessar i ly linked to the GTP-bind ing pro-
tein and therefore dissociation is not influenced by GTP ? 
Lohse: 
When you think about agonists, -we are always having adenylate 
cyclase in our mind and then you would always see that. But of 
co~rse, there are possible other ways of adenosine mechanisms 
wh~ch we have not investigated. 
Fredholm: 
Wouldn't that be nice if you had two different types of confor-
mations and barbiturates could only act on one type of confor-
. mation? 
Daly: 
Have you looked at the stimulatory Ra-receptor? I am thinking 
on adenylate cyclase activation. 
Lohse: 
We are just studying this. 
Dunwiddie: 
At least two other classes of compounds have been reported to 
have barbiturate-like effects. Etomidate is one, it is an 
anaesthetic drug. It fasciltates GABA -ergic inhibition in 
brain slices. so, it acts like barbiturates and it also re-
gulates the GABA-binding. I was wendering whether you have 
looked at other classes of compounds which look biochemically 
and functionally like barbiturates in order to see whether they 
are adenosine antagonists or agonists. 
Lohse: 
Yes, we have also looked at etomidate • The problern is that it 
is active with a Ki value of about 100 micromolar which is re-
~at~vely high compared to its anaesthetic concentration, which 
~s ~n the range of 6 micromolar. So, that appears not too rele-
v~nt. And secondly, the stereoisomeres of etomidate have Vf7CY 
d~fferent pharmacological activities. I don't rem:mber whl~h 
one is anaesthetic· one of them does absolutely nothlng. But ~n 
our system they do'practically the same. so, I d~n't think that 
this mechanism is particularly relevant for etom1date. 
Phillis: 
Your data are somewhat reminiscent of the data on carbamazepine 
which has been reported to be an adenosine receptor ligand 
(Skerrit et al. Epilepsia, 24,643, 1983 ). But in Marangos' 
hands ( Europ. J. Pharmacol. 83, 175, 1~83.> it is.an ad~nosine 
receptor antagonist, again based on b1nd1ng stud1es whlch are 
very similar to the ones which you have done. 
Lohse: 
Yes, that is very similar, indeed. 
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